Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03440229 · ClinicalTrials.gov registry record · NA
Functional Research of Emulsifiers in Humans
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT03440229: Completed NA study, sponsored by University of Pennsylvania.
NCT03440229 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03440229, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
A randomized double-blind study of the effect of carboxymethylcellulose (CMC) on stool microbiota composition, microbiota localization, and metabolic parameters in healthy subjects. It includes a 11-day in-patient stay, randomization to an emulsifier-free group or a CMC group with the same diet except baked goods/sorbet with added CMC at 15g/person/day.
Interventions
- OTHER Emulsifier-containing diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2018-04-06 |
| Est. Completion | 2019-05-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03440229
The ClinicalTrials.gov registry entry for NCT03440229 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Emulsifier-containing diet is the first listed.
NCT03440229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03440229 about?
NCT03440229 is a clinical study titled "Functional Research of Emulsifiers in Humans". A randomized double-blind study of the effect of carboxymethylcellulose (CMC) on stool microbiota composition, microbiota localization, and metabolic parameters in healthy subjects. It includes a 11-day in-patient stay, randomization to an emulsifier-free group or a CMC group with the same diet exce...
What is the current status of trial NCT03440229?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2018-04-06. Estimated completion is 2019-05-13.
What interventions are being tested in trial NCT03440229?
The interventions under investigation include: Emulsifier-containing diet (OTHER).
Who is sponsoring clinical trial NCT03440229?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.